ソウルで最高のスリング手術医師 - トップ4名の医師

パク医師はソウルミズ病院において婦人科処置を専門とする最高医療責任者であり、尿失禁治療に豊富な専門知識を有しています。

• 尿失禁に対するスリング手術を実施
• 忠南大学医学部卒業
• 国内複数の名門大学における客員教授
• 日本産科婦人科学会会員

Dr. Ki Yeol Yang, MD, PhD, is the Founder and Representative Director of Trinity Women’s Clinic. She is a menopause specialist and a pioneer in uterus-preserving, minimally invasive gynecology. She is a Korean board-certified OB/GYN and a certified menopause specialist (Korean Menopause Society). Her practice, informed by tens of thousands of clinical cases, provides individualized HRT and precision care.

She is experienced in HIFU and RFA for fibroids and adenomyosis, laser vaginal rejuvenation, and functional pelvic floor reconstruction. She is a Clinical Professor at Kyung Hee University Medical Centre. She serves as Director of Academic Affairs for the Korean Medical Practitioners’ Association and as Business Director for the Korean Therapeutic Ultrasound Medical Association. She is also the author of a menopause patient guide.

Founder of Trinity Women’s Clinic. Recognized as a Master Surgeon in minimally invasive gynecology and female aesthetic surgery. Pioneers uterus‑preserving, scar‑less care using RFA, HIFU, and ovarian sclerotherapy.

Professor of Non‑surgical Female Plastic Surgery at IFAAS. Leads international RFA Master Classes in Taiwan and Mongolia. Director of General Affairs at the Korean Society of HIFU. Holds director roles with KMPA, KCOG, and the Korean Society of Therapeutic Ultrasound.

MD/PhD, Korea University. Fellowship in Gynecologic Oncology at Korea University Medical Center. HIFU training at Fudan University. Preceptorship at Uppsala University. Former Medical Affairs executive at MSD, Takeda, and Novo Nordisk. Key Doctor and consultant to Bayer, Novo Nordisk, PharmaResearch, and RF Medical. Member of AACR and IGCS. Medical advisor on Channel A and TV Chosun.

HEESEOK KANGDepartment of Obstetrics

• Education/Academic career
• Graduated from Yonsei University College of Medicine
• Internship, Samsung Medical Center
• Residency and M.D., Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Pocheon Hospital
• Clinical Instructor, Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology I, Good Morning Hospital
• Head of Department, Obstetrics and Gynecology, Daerim St. Mary’s Hospital
• Director of Obstetrics and Gynecology & Academic Affairs of Medical Department , Hismedi Hospital
• Head of Department, Heryoujae Women’s Hospital
• Current)Adjunct Professor, Obstetrics and Gynecology, Samsung Medical Center
• Current)Expert for NAVER KnowledgeiN
• Professional memberships
• Award for Exemplary Safety Management, Samsung Medical Center, 2002
• Award for Excellence in QI Poster, Samsung Medical Center, 2007
• Outstanding Thesis Award, Korean Society of Gynecologic Oncology and Colposcopy, 2008
•  
• [Thesis]
•  
• 1. Single port access laparoscopic adnexal surgery. Kim TJ, Lee YY, Kim MJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. J Minim Invasive Gynecol. 2009 SepOct;16(5):6125.
• 2. The prognostic significance of the SUVmax (maximum standardized uptake value for F18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Gynecol Oncol. 2009 Oct;115(1):658. Epub 2009 Jul 15.
• 3. Singleport access laparoscopicassisted vaginal hysterectomy: a novel method with a wound retractor and a glove. Lee YY, Kim TJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. J Minim Invasive Gynecol. 2009 JulAug;16(4):4503. Epub 2009 May 31.
• 4. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a singleinstitutional phase II study. Kang H, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG. Gynecol Oncol. 2009 Aug;114(2):2104. Epub 2009 May 14.
• 5. MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node Metastasis. Ryoo UN, Choi CH, Yoon JY, Noh SK, Kang H, Kim WY, Kim BH, Kim TJ, Lee JW, Lee JH, Kim BG, Bae DS. Cancer Res Treat. 2007 Dec;39(4):16570. Epub 2007 Dec 31.
• 6. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Choi CH, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199204.
• 7. Lowgrade endometrial stromal sarcoma: a single center's experience with 22 cases. Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS. Int J Gynecol Cancer. 2008 SepOct;18(5):10849.
• 8. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Gynecol Oncol. 2008 Oct;111(1):10610.
• 9. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. BMC Cancer. 2008 Oct 11;8:295.
• 10. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. JKMS. 2009 Oct. (in press)
• 11. Ritodrine hydrochloride 단독 투여와 magnesium sulfate와의 병합 투여의 조기진통 억제효과 및 안정성에 대한 비교 김영아, 강희석, 양순하, 김종화 대한산부인과학회 2002;45:1991.
• 12. Experience of Surgical Treatment for Adnexal Lesions in Adolescent Patients 이은주, 강희석, 윤병구, 배덕수, 최두석 대한산부내시경 2002;14:79
• 13. 태아간 수혈증후군이 의심되는 단일 융모막성 쌍태임신에서 발견된 일측 쌍생아의 선천성 뇌실주위 백질 연화증 1예 강희석, 양순하, 오성희, 강병희, 노정래, 김종화 대한산부인과학회 2002:45:841
• 14. 자궁근종 치료에서 modified LAM 기법의 타당성 조사 연구 이은주, 김태중, 지현영, 김하정, 김철중, 이유영, 강희석, 최철훈, 이정원, 김병기, 배덕수 대한산부내시경 2008;20:35
• 15. 위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고 최현진, 최철훈, 김태중, 강희석, 이은주, 이정원, 김병기, 이제호, 배덕수 대한산부인과학회 2008;51:1519
• 16. Factors associated with complicationsand conversion to laparotomy in women undergoing laparoscopically assistedvaginal hysterectomy. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Acta Obstet Gynecol Scand. 2012 May;91(5):6204.
• 17. A review of the technique and complicationsfrom 2,012 cases of laparoscopically assisted vaginal hysterectomy at a singleinstitution. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):23943.
• 18. The use of misoprostol beforehysteroscopic surgery in nonpregnant premenopausal women: a randomizedcomparison of sublingual, oral and vaginal administrations. Lee YY, Kim TJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. Hum Reprod. 2010 Aug;25(8):19428.
• 19. Prognostic significance of pSTAT3 inpatients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS. J Obstet Gynaecol Res. 2010 Apr;36(2):30410.
• 20. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposideand cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.